Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2025-12-24 @ 2:32 PM
NCT ID:
NCT00002359
Eligibility Criteria:
Inclusion Criteria
Concurrent Medication:
Allowed:
* Antiretrovirals if on a stable dose for at least the past 3 months.
Patients must have:
* HIV-1 infection with CD4 count 300-549 cells/mm3.
* No AIDS-defining condition.
* Been on a stable dose of antiretroviral for the past 3 months, if taking antiretrovirals.
NOTE:
* KS is permitted if not requiring systemic therapy.
Prior Medication:
Allowed:
* Prior antiretrovirals.
Exclusion Criteria
Concurrent Medication:
Excluded:
* Systemic chemotherapy for KS.
* Treatment for malignancy other than basal cell or squamous cell carcinoma of the skin or carcinoma in situ of the cervix.
Patients with the following prior conditions are excluded:
* History of any illness that would interfere with study.
* Acute infection requiring prescription therapy within the past month, other than genital herpes and oral or vaginal candidiasis.
Prior Medication:
Excluded:
* Prior HIV-1 Immunogen. Unwilling to use effective safe sex practices. Active substance abuse.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00002359
Study Brief:
Protocol Section:
NCT00002359